Publications Office of the EU
Germany-Munich: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Germany-Munich: Pharmaceutical products

Overview
  • Awarded
    12/11/2020
  • Today
    08/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Bayern – Die Gesundheitskasse
Place of performance
NUTS code: DE2 Bayern
Location of buyer
NUTS code: DE2 Bayern
Business sector (Main CPV)
33600000 33600000
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
1.00 EUR
Procedure details
Tender reference number
Not available
Description

Die AOK Bayern beabsichtigt, mit dem Hersteller des Arzneimittels Maviret (Wirkstoff: Glecaprevir/Pribentasvir, ATC-Code J05AP07) einen Vertrag gemäß § 130 c SGB V abzuschließen. Es handelt sich bei dieser Bekanntmachung um eine Bekanntmachung gemäß § 135 Abs. 3 GWB.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
DE2 Bayern
CPV code

33600000 - 33600000

Award method
Lowest price
Estimated value
Not available
Final contracted value
1.00 EUR
Award of contract
Official name: AbbVie Deutschland GmbH & Co. KG
Postal address:
Town: Wiesbaden
Postal code:
Country: DEU
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.